Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2020)
Cumberland Pharmaceuticals' (CPIX) quarterly Change in Acquisitions & Divestments came in at -$460888.0 in Q4 2020, down 110.53% year-on-year from $4.4 million in Q1 2020, and down 200.0% quarter-over-quarter from $460888.0 in Q3 2020.
Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2012 - 2020) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting -$460888.0 for Q4 2020.
- Change in Acquisitions & Divestments for Q4 2020 came in at -$460888.0, down 110.53% year-over-year; the trailing twelve-month figure through Sep 2020 was $4.8 million (down 69.17% YoY), and the FY2019 annual result was $20.1 million, up 24.44% from the prior year.
- Change in Acquisitions & Divestments came in at -$460888.0 for Q4 2020 at Cumberland Pharmaceuticals, down from $460888.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.2 million in Q3 2018 to a low of -$460888.0 in Q4 2020.
- The 5-year median for Change in Acquisitions & Divestments is $2.1 million (2016), against an average of $3.2 million.
- Across the five-year window, Change in Acquisitions & Divestments jumped 972.73% in 2017 and tumbled 110.53% in 2020, its largest moves.
- Cumberland Pharmaceuticals' Change in Acquisitions & Divestments stood at $812366.0 in 2016, then soared by 359.95% to $3.7 million in 2017, then jumped by 146.71% to $9.2 million in 2018, then slumped by 52.53% to $4.4 million in 2019, then sank by 110.53% to -$460888.0 in 2020.
- The last three Change in Acquisitions & Divestments figures came in at -$460888.0 (Q4 2020), $460888.0 (Q3 2020), and $4.4 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -460,888.00 |
| Dec 31, 2020 | -460,888.00 |
| Sep 30, 2020 | 460,888.00 |
| Sep 30, 2020 | 460,888.00 |
| Dec 31, 2019 | 4.38 Mn |
| Dec 31, 2019 | 4.38 Mn |
| Sep 30, 2019 | 7.12 Mn |
| Sep 30, 2019 | 7.12 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Jun 30, 2019 | 2.08 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Mar 31, 2019 | 6.48 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Sep 30, 2018 | 9.22 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 4.26 Mn |
| Mar 31, 2018 | 4.26 Mn |
| Dec 31, 2017 | 3.74 Mn |
| Dec 31, 2017 | 3.74 Mn |